Immunic Therapeutics

Immunic is a biotechnology company developing small molecule therapies for chronic inflammatory and autoimmune diseases

Biotechnology Research · New York

About

Immunic (Nasdaq: IMUX) is a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases. Privacy Policy: https://imux.com/privacy-policy/

Details

  • Website: https://imux.com
  • Founded: 2016
  • Company Size: 90 employees
  • Headquarters: New York City, New York